跳至主要内容
临床试验/CTRI/2019/08/020496
CTRI/2019/08/020496尚未招募未知

Enhanced recovery after surgery in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis- compliance, safety & efficacy â?? a pilot study

il0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • . Patients with a peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
  • ii. Peritoneal carcinomatosis Index (PCI) Score any iii. Age >18 years and <65 years
  • iv. European Cooperative Oncology Group (ECOG) Performance status 0-1
  • vi. No functional disturbance in bone marrow; WBC at least 3,000/mm3, Platelet count of atleast125,000/mm3.
  • vii. No functional disturbance in liver; Bilirubin less than 2.5 mg/dL, PT-INR < 1.5
  • viii. No function disturbance in kidney; Creatinine no greater than 1.5 times upper limit of normal.

排除标准

  • 未提供

研究者

发起方
il

相似试验